Treatment for anemia in patients with Stage-4 Chronic Kidney Disease (CKD) focuses on achieving a specific blood hemoglobin level. The goal is typically to raise the hemoglobin concentration to improve symptoms and quality of life, while avoiding excessive levels.
For patients in Stage-4 CKD experiencing anemia, the recommended target blood hemoglobin level is generally maintained between 10 to 12 gm/dL. This range aims to balance therapeutic benefits with potential risks associated with higher hemoglobin levels.
LaTeX representation of the target range: $10 \text{ to } 12 \text{ gm/dL}$